Home/Filings/4/0001179110-12-005376
4//SEC Filing

GETLIN LAWRENCE W 4

Accession 0001179110-12-005376

CIK 0001222244other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 1:57 PM ET

Size

11.1 KB

Accession

0001179110-12-005376

Insider Transaction Report

Form 4
Period: 2012-03-16
Transactions
  • Award

    Common stock, $0.00001 par value

    2012-03-16$1.00/sh+8,450$8,45036,178 total
Holdings
  • Stock Options

    Exercise: $0.87Exp: 2018-08-09Common stock, $0.00001 par value (28,736 underlying)
    28,736
  • Convertible Note

    Exercise: $1.10Exp: 2012-02-28Common stock, $0.00001 par value
  • Stock Options

    Exercise: $0.92Exp: 2018-02-27Common Stock, $0.00001 par value (2,265 underlying)
    2,265
  • Convertible notes

    Exercise: $1.30Exp: 2013-09-15Common Stock, $0.00001 par value (19,231 underlying)
Footnotes (5)
  • [F1]Options vest as to 189 shares per month begining July 27, 2011, and as to 185 shares on June 27, 2012.
  • [F2]Currently exercisable.
  • [F3]Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors at its annual shareholders's on August 9, 2011; meeting. The seven-year options vest ratably over 12 months.
  • [F4]On December 1, 2011, the reporting person and the Company executed a convertible promissory note in the principal amount of $5,200 with a maturity date of February 28, 2012. The principal amount and interest accruing at a rate of 10% per year are convertible into common shares at $1.10 per share at any time through the maturity date. The number of shares to be issued upon conversion will be fixed on the conversion date and reported on a Form 4 within 2 business days after conversion. The issuer's Board of Directors specifically approved the transaction as exempt from the requirements of Section 16b as provided by Rules 16b-3(d).
  • [F5]On March 16, 2012, the issuer issued 8,450 shares to the reporting person in lieu of cash for $8,450 of consulting fees due to the reporting person. The issuer's Board of Directors specifically approved the transaction as exempt from the requirements of Section 16b as provided by Rules 16b-3(d).

Issuer

ProUroCare Medical Inc.

CIK 0001222244

Entity typeother

Related Parties

1
  • filerCIK 0001230359

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 1:57 PM ET
Size
11.1 KB